William Grossman

“On June 14, 2026, the Board appointed Dr. William Grossman, a current member of the Board and chair of the Board's Research and Development Committee, to the position of Interim Chief Medical Officer of the Company, effective June 15, 2026.”

“the Board increased its size from seven members to nine and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed William Grossman and Michael Heffernan to the Board as directors, each with a term expiring at the Company's first annual general meeting of shareholders following his appointment, or until such director's successor is duly elected and appointed or his earlier death, resignation, or removal.”